Glen J. Weiss

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer”.

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.05.028

N/A

0DataRank · unranked

22 citations

Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri +10 more

Financial Conflicts of Interest Change After a High-Impact Clinical Trial Publication in Oncology

Journal of patient-centered research and reviews(2020)10.17294/2330-0698.1735

N/A

0DataRank · unranked

2 citations

Emily Stern Gatof, Glen J. Weiss, Roger B. Davis, Craig L. Cambridge